Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.14
+1.22 (10.23%)
At close: Jan 16, 2026, 4:00 PM EST
13.30
+0.16 (1.22%)
After-hours: Jan 16, 2026, 7:59 PM EST
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.74 billion as of January 16, 2026. Its market cap has decreased by -53.84% in one year.
Market Cap
1.74B
Enterprise Value
1.80B
1-Year Change
-53.84%
Ranking
Category
Stock Price
$13.14
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.74B, an increase of 566.54%. That is a compound annual growth rate of 77.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.74B | 16.39% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |